Celltrion Launches Remsima SC In UK

Innovative Subcutaneous Infliximab Also Receives Korean Approval

 
• By David Wallace
  
UK_Map_Blue
Celltrion Has Launched Its Remsima SC In The UK From The Start Of March • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products